APA (7th ed.) Citation

Eisses, B., Angus, L., Kuip, E. J. M., Menke-van der Houven van Oordt, C. W., van der Vegt, B., Glaudemans, A. W. J. M., . . . Schröder, C. P. (2026). Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer. Diagnostics (2075-4418), 16(8), 1197. https://doi.org/10.3390/diagnostics16081197

Chicago Style (17th ed.) Citation

Eisses, Bertha, et al. "Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer." Diagnostics (2075-4418) 16, no. 8 (2026): 1197. https://doi.org/10.3390/diagnostics16081197.

MLA (9th ed.) Citation

Eisses, Bertha, et al. "Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer." Diagnostics (2075-4418), vol. 16, no. 8, 2026, p. 1197, https://doi.org/10.3390/diagnostics16081197.